HEALTHCARE & MEDICARE
-
AmplifyMD snags $20 million to help hospital-scale virtual professional nursing
AmplifyMD, a virtual professional care platform designed to help hospitals do more and more with fewer doctors, received $20 million…
Read More » -
WTW: Half of employers surpass their healthcare budget in 2024
It’s no secret that employers are struggling with health care costs. A new survey by Willis Towers Watson shows that…
Read More » -
Healthcare safety awakening tests the patience of medical device buyers
Healthcare buyers have reached a turning point after accepting cybersecurity as a problem with others. If costs and features once…
Read More » -
However, it moved – Healthcare Blog
Kim Bellard Science enthusiasts will recognize the title as (probably pseudo-Scripture) citing Galileo’s claim to be forced to withdraw his…
Read More » -
Capital RX rebrands into Judi Health, earning $400 million investment
The company announced Tuesday that transparent pharmacy benefits manager Capital RX has received a $400 million investment and has been…
Read More » -
Ionis Pharma's Rare Disease Drugs Not Approved Therapy Meets Critical Research Targets
Patients with specific genetic disorders whose symptoms include a progressively worsening muscle control can walk faster after experimental Ionis Pharmaceuticals…
Read More » -
Promote, not information, for participation and adoption
You have groundbreaking medical devices or digital health applications and data to show improved health outcomes or lower costs. You…
Read More » -
New bereavement cost calculator shows that sadness is expensive – Healthcare Blog
Emma Payne Sadness is expensive. In addition to major human impacts, studies have shown that bereavement leads to a 20%-30%…
Read More » -
AI hallucinations: What are they, always terrible?
Hallucinations are a regular focus of conversations about healthcare AI. But what do they actually mean in practice? This is…
Read More » -
Pfizer's $4.9B Metsera acquisition makes it a major player in obesity drugs and more people
Pfizer's internal obesity drug development stumbled upon, but the drug giant passed a billion-dollar acquisition of the multi-billion-dollar clinical-stage company…
Read More »